7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-09-30 2018-06-30 2018-03-31 2017-09-30 2017-06-30 2017-03-31 2016-09-30 2016-06-30 2016-03-31 2015-09-30 2015-06-30 2015-03-31 2014-09-30 2014-06-30 2014-03-31 2013-09-30 2013-06-30 2013-03-31 2012-09-30 2012-06-30 2012-03-31 2011-09-30 2011-06-30 2011-03-31 2010-09-30 2010-06-30 2010-03-31 2009-09-30 2009-06-30 2009-03-31 2008-09-30 2008-06-30 2008-03-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 
      
    		                                                                     
      cash flows from operating activities:
    		                                                                     
      consolidated net income
    		-58,500,000 4,200,000 16,800,000     204,600,000 88,700,000 57,800,000 77,400,000 98,300,000 88,400,000 49,700,000 62,100,000 76,000,000 88,100,000 58,700,000 57,800,000 71,300,000 55,300,000 24,200,000 10,600,000 68,800,000 61,500,000 37,000,000 30,700,000 44,200,000 31,500,000 27,400,000 37,600,000 24,000,000 21,700,000 47,000,000 14,800,000 23,600,000 12,900,000 23,100,000 6,900,000 6,300,000 16,800,000 10,000,000 16,900,000 23,300,000 5,700,000 39,900,000 9,900,000 15,100,000 20,100,000 22,600,000 11,700,000 27,900,000 22,900,000 16,000,000  12,700,000 8,600,000             
      adjustments to reconcile net income to cash flows from operating activities:
    		                                                                     
      depreciation and amortization
    		55,700,000 56,100,000 50,400,000 52,900,000 51,000,000 45,200,000 34,700,000 37,300,000 26,600,000 25,900,000 25,100,000 24,500,000 21,000,000 21,600,000 21,700,000 23,000,000 22,200,000 21,600,000 22,300,000  20,500,000 19,200,000 19,000,000  18,900,000 19,400,000 19,000,000 15,900,000 16,600,000 15,800,000 17,100,000 16,000,000 15,100,000 13,700,000 13,500,000 13,200,000 13,300,000 13,200,000 13,500,000 17,600,000 14,800,000 15,200,000 15,200,000 15,000,000 15,200,000 13,900,000 15,000,000 13,600,000 13,600,000 13,800,000 11,900,000 9,100,000 7,200,000 7,500,000 7,100,000 7,000,000 6,800,000             
      deferred income taxes
    		-26,600,000 -15,900,000 -22,700,000 -19,600,000 -21,900,000 -20,200,000 -2,100,000 -37,200,000 3,400,000 8,200,000 1,200,000 10,900,000 -17,500,000 -4,200,000 -4,000,000 700,000 -2,700,000 -8,700,000 4,900,000  1,600,000 -2,200,000 1,100,000  -200,000        400,000        0 300,000                            
      impairment of goodwill, intangible assets, other long-lived assets, and certain minority investments
    		                                                                     
      other non-cash expenses
    		-33,300,000 -11,600,000 11,200,000    -6,100,000 13,800,000 2,300,000 11,000,000 5,000,000 6,500,000 7,900,000 10,100,000 -6,200,000 2,100,000 4,000,000 15,900,000 4,900,000  6,300,000 7,500,000 11,700,000  -4,400,000 1,600,000 4,500,000 -8,900,000 6,600,000 18,200,000 4,300,000 500,000 1,300,000 3,700,000 7,300,000 1,700,000 8,600,000 -6,400,000 7,300,000 9,900,000 500,000 700,000         600,000                   
      changes in operating assets and liabilities, net of acquisitions and divestitures:
    		                                                                     
      income taxes payable
    		-25,200,000   2,100,000 5,000,000 -10,500,000 -11,900,000 57,200,000 4,300,000 -12,000,000 -5,800,000 -17,400,000 27,100,000 -17,100,000 600,000 -10,900,000 -40,400,000 -3,100,000 10,100,000  -6,000,000 11,900,000 -15,000,000  12,800,000                6,800,000 2,000,000                            
      accounts payable and accrued expenses
    		    20,900,000 9,300,000 -3,700,000 12,000,000 14,500,000 -16,500,000 13,100,000 12,900,000 17,600,000 -17,200,000 -100,000 15,500,000 32,900,000 -22,500,000 35,500,000  800,000 -35,200,000 19,100,000  7,500,000 -8,200,000 11,000,000             15,800,000 -13,000,000 21,900,000                            
      other changes in operating assets and liabilities
    		100,000   114,100,000 8,000,000 -12,300,000 -30,300,000 25,400,000 -12,400,000 -20,900,000 -20,200,000 15,900,000 200,000 -15,300,000 1,800,000 31,300,000 -20,300,000 -13,100,000 -17,100,000  -1,600,000 10,200,000 -20,400,000  -10,300,000     2,300,000 2,700,000 -2,800,000 5,500,000                   24,300,000                  
      net cash from operating activities
    		-33,200,000 -127,500,000 65,000,000 190,000,000 38,400,000 1,100,000 21,800,000 205,500,000 44,100,000 13,000,000 87,500,000 171,500,000 69,500,000 -44,400,000 77,800,000 138,600,000 23,900,000 21,900,000 98,000,000 203,000,000 82,400,000 11,800,000 35,000,000 136,200,000 52,400,000 10,600,000 14,200,000 27,500,000 36,100,000 43,800,000 35,300,000 -17,200,000 32,600,000 35,900,000   54,100,000 -1,500,000 27,000,000 13,500,000 13,000,000 18,500,000    300,000      9,600,000 47,600,000 5,500,000 16,000,000 38,200,000 13,100,000 899,000 -4,230,000 22,333,000 -3,797,000 -6,807,000 451,000 19,858,000 17,575,000 1,935,000 -1,675,000 -25,535,807 3,918,000 
      capex
    		-20,900,000 -21,300,000 -26,000,000 -36,700,000 -32,600,000 -24,600,000 -21,400,000 -31,500,000 -26,900,000 -23,500,000 -25,000,000 -34,600,000 -57,700,000 -17,900,000 -19,000,000 -28,400,000 -16,300,000 -22,600,000 -24,700,000 -28,800,000 -17,600,000 -20,300,000 -30,500,000 -28,200,000 -16,200,000 0 0 0 0 0 0 0 0 0   0 0 0 0 0 0    0      0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
      free cash flows
    		-54,100,000 -148,800,000 39,000,000 153,300,000 5,800,000 -23,500,000 400,000 174,000,000 17,200,000 -10,500,000 62,500,000 136,900,000 11,800,000 -62,300,000 58,800,000 110,200,000 7,600,000 -700,000 73,300,000 174,200,000 64,800,000 -8,500,000 4,500,000 108,000,000 36,200,000 10,600,000 14,200,000 27,500,000 36,100,000 43,800,000 35,300,000 -17,200,000 32,600,000 35,900,000   54,100,000 -1,500,000 27,000,000 13,500,000 13,000,000 18,500,000    300,000      9,600,000 47,600,000 5,500,000 16,000,000 38,200,000 13,100,000 899,000 -4,230,000 22,333,000 -3,797,000 -6,807,000 451,000 19,858,000 17,575,000 1,935,000 -1,675,000 -25,535,807 3,918,000 
      cash flows from investing activities:
    		                                                                     
      purchases of property, plant and equipment
    		-20,900,000 -21,300,000 -26,000,000 -36,700,000 -32,600,000 -24,600,000 -21,400,000 -31,500,000 -26,900,000 -23,500,000 -25,000,000 -34,600,000 -57,700,000 -17,900,000 -19,000,000 -28,400,000 -16,300,000 -22,600,000 -24,700,000 -28,800,000 -17,600,000 -20,300,000 -30,500,000 -28,200,000 -16,200,000                                             
      cash paid for acquisitions, net of cash acquired
    		-200,000 -68,400,000 -1,100,000 -22,900,000 -200,000 -1,302,000,000 -274,500,000 -4,300,000 -119,600,000 -14,600,000 -88,100,000 -96,800,000 -100,000   -20,000,000 -41,000,000 0 -4,000,000                                                   
      other investing activities
    		-2,700,000 -1,400,000 1,000,000                                                                   
      net cash from investing activities
    		-23,800,000 -91,100,000 -26,100,000 -60,600,000 -67,600,000 -1,324,900,000 -304,200,000 -36,800,000 -155,000,000 -26,000,000 -108,200,000 -149,300,000 -57,600,000 57,100,000 -101,800,000 -48,600,000 -48,400,000 -71,400,000 -24,000,000 -28,800,000 -48,200,000 -15,100,000 -100,600,000 -39,200,000 -12,600,000   -29,100,000 -46,100,000 108,100,000                                  -1,406,000 -26,820,000 27,191,000 13,334,000   
      cash flows from financing activities:
    		                                                                     
      repayments of revolving line of credit
    		-574,700,000 -51,200,000 -167,900,000  -148,500,000 -839,600,000 -500,000                                                               
      proceeds from revolving line of credit
    		457,300,000 168,300,000 139,900,000  100,000 804,400,000 268,900,000                                                               
      repayment of long-term debt
    		-299,000,000 -14,600,000 -7,700,000    -3,400,000                                                               
      proceeds from long-term debt
    		0 0 2,900,000      400,000                                                             
      proceeds from issuance of series a mandatory convertible preferred stock, net of issuance costs
    		                                                                     
      proceeds from issuance of common stock
    		-1,200,000 4,900,000 400,000    3,400,000 4,700,000 2,000,000 2,100,000 700,000 2,000,000 -2,500,000 200,000 3,100,000 1,100,000 3,700,000 1,100,000 1,100,000        3,100,000 1,900,000 4,400,000 2,600,000 6,100,000 8,000,000 1,200,000 600,000 2,100,000 7,500,000 800,000 2,900,000 3,300,000 2,500,000 1,800,000 3,000,000 3,500,000 400,000 4,100,000 200,000 1,600,000 1,800,000 100,000 500,000 2,500,000          447,000 455,000 17,962,000  369,000 40,000 9,000  202,000 
      payment of dividends to common shareholders
    		0 -7,600,000 -7,700,000 -7,600,000 -7,600,000 -7,700,000 -7,300,000 -7,300,000 -7,400,000 -7,300,000 -7,400,000 -7,400,000                                                          
      repurchase of common stock
    		0 0 -10,000,000     -50,400,000 -79,500,000 0 -22,400,000 -26,300,000 -70,900,000 -60,300,000 -105,600,000                                                       
      other financing activities
    		6,500,000 -4,300,000 -1,100,000                                                                   
      net cash from financing activities
    		258,400,000 95,500,000 -51,200,000 -75,000,000 -2,700,000 1,155,800,000 151,700,000 -59,900,000 -92,500,000 -10,300,000 -30,700,000 -36,100,000 -82,000,000 -79,800,000 -217,400,000 404,300,000 -2,600,000 -44,900,000 -38,100,000  -225,500,000 -53,100,000 191,300,000  -19,500,000              4,100,000 3,000,000 700,000 2,500,000 22,100,000 2,400,000 300,000 15,700,000              355,935,000 4,509,000 -806,000 7,183,000   -565,000 1,250,000   
      effect of exchange rate changes on cash, cash equivalents and restricted cash
    		-300,000 31,600,000 13,300,000 -19,400,000 10,400,000 -2,100,000 -17,600,000 15,900,000 -7,900,000 100,000 4,100,000 33,300,000 -26,900,000 -26,200,000 -10,700,000 900,000 -8,100,000 5,700,000 -21,000,000  11,500,000 7,900,000 -8,700,000  -6,800,000     5,800,000 2,700,000 6,900,000 5,800,000                                     
      net increase in cash, cash equivalents and restricted cash
    		  1,000,000                                                                   
      cash, cash equivalents and restricted cash at beginning of period
    		0 0 186,700,000  0 0 491,600,000  0 0 648,700,000  0 0 1,071,700,000  0 0 685,500,000  0 0 681,900,000  0 0 326,300,000 0 0 328,900,000 0 0 345,900,000                                     
      cash, cash equivalents and restricted cash at end of period
    		201,100,000 -91,500,000 187,700,000  -21,500,000 -170,100,000 343,300,000  -211,300,000 -23,200,000 601,400,000  -97,000,000 -93,300,000 819,600,000  -35,200,000 -88,700,000 700,400,000  -179,800,000 -48,500,000 798,900,000  13,500,000 -16,100,000 302,600,000 12,300,000 -25,300,000 287,800,000 46,400,000 -59,300,000 280,700,000                                     
      supplemental disclosure of cash flow information:
    		                                                                     
      cash paid for interest
    		14,700,000                                                                     
      cash paid for taxes
    		38,700,000                                                                     
      restricted cash period beginning balance
    		0 0 3,300,000 0 0 0 3,300,000 0 0 0 3,200,000 0 0 0 3,500,000 0 0 0 3,700,000 0 0                                                 
      restricted cash period ending balance
    		0 700,000 3,500,000 -300,000 100,000 300,000 3,200,000 0 -100,000 -100,000 3,500,000 100,000 -200,000 -200,000 3,500,000 0 -100,000 0 3,600,000 200,000 -100,000                                                 
      net decrease in cash, cash equivalents and restricted cash
    		                                                                     
      changes in operating assets and liabilities, net of acquisitions and divestitures
    		  9,300,000                                                                   
      adjustments to reconcile consolidated net income to cash flows from operating activities:
    		                                                                     
      stock-based compensation expense
    		   6,800,000 6,300,000 6,900,000 5,300,000 6,200,000 5,700,000 5,600,000 6,500,000 4,700,000 5,300,000 9,700,000 8,000,000 5,300,000 4,200,000 3,900,000 3,800,000  4,500,000 3,100,000 3,300,000  4,000,000 3,000,000 3,100,000 3,300,000 2,400,000 2,500,000 3,100,000 2,700,000 2,600,000 2,500,000 2,100,000 2,200,000 2,200,000 1,400,000 2,200,000 2,100,000 3,000,000 2,000,000 1,600,000 1,400,000 1,800,000                         
      bargain purchase gain on acquisition and associated measurement period adjustments
    		                                                                     
      impairment of minority investments and other long-lived assets
    		   1,000,000 5,900,000 20,200,000 1,400,000    6,900,000                                                           
      loss on sale of minority investment
    		                                                                     
      gain on sale of property, plant and equipment
    		   2,100,000 1,700,000   900,000 200,000 200,000 -9,800,000                                                           
      changes in operating assets and liabilities, net of acquisitions:
    		                                                                     
      accounts receivable
    		   -51,300,000 -18,800,000 13,900,000 15,600,000 11,500,000 -42,900,000 22,200,000 8,300,000 -28,200,000 -35,300,000 -2,000,000 -2,400,000 -47,600,000 -39,200,000 -9,300,000 800,000  2,600,000 4,800,000 29,500,000  -18,600,000    26,600,000 10,000,000  -8,700,000 25,600,000 -14,900,000 23,100,000 7,200,000 -4,900,000 -8,900,000 51,500,000 -7,400,000 16,100,000 12,800,000   8,700,000 -11,400,000 7,700,000 28,900,000     4,900,000 4,500,000 -13,400,000 19,700,000 20,600,000             
      inventories
    		   35,300,000 -11,100,000 -29,200,000 -64,800,000 22,300,000 -32,900,000 -59,400,000 -55,000,000 1,200,000 -34,500,000 -55,600,000 -49,000,000 14,300,000 -13,000,000 -26,700,000 -41,600,000  -12,700,000 -36,000,000 -61,000,000  -11,100,000                                             
      accounts payable
    		                                              -6,800,000 10,800,000 -1,400,000 -1,300,000 14,300,000 1,500,000 3,400,000 5,900,000   6,600,000             
      deferred revenue and customer advances
    		   -3,500,000 -51,400,000 -29,600,000 31,700,000 -7,100,000 -14,600,000 -13,700,000 34,800,000                                                           
      maturity of short-term investments
    		           0 0   97,500,000                       21,500,000                               
      proceeds from sale of minority investment
    		                                                                     
      cash paid for minority investments
    		   -2,300,000 -36,000,000 0 -10,000,000                                                               
      proceeds from sales of property, plant and equipment
    		   200,000 0 400,000 500,000 200,000 200,000 0 10,700,000 100,000 0 1,100,000 12,700,000 900,000 1,600,000 1,200,000 1,200,000     0 10,700,000   0   0 300,000 6,600,000 0 300,000 600,000 0   1,800,000                              
      net proceeds from cross-currency swap agreements
    		   1,100,000 1,200,000 1,300,000 1,200,000 1,300,000 1,300,000 1,400,000 2,400,000 1,400,000 2,900,000      3,500,000                                                   
      repayments of revolving lines of credit
    		                                                                     
      proceeds from revolving lines of credit
    		                          40,600,000 20,000,000   75,000,000 46,000,000 33,000,000 22,000,000 41,000,000 36,000,000 7,000,000                                 
      payment of deferred financing costs
    		   0 0 -800,000 -4,700,000                                                               
      proceeds from public offering of common stock, net of issuance costs
    		   0 100,000                                                                 
      proceeds from issuance of common stock under employee stock plans
    		   3,200,000 -2,900,000                                                                 
      payment of contingent consideration
    		   -3,300,000 -900,000   0 -200,000 -1,500,000 -1,000,000 -1,000,000 3,100,000 -3,600,000 -1,200,000 0 0 0 -400,000                                                   
      proceeds from the sale (payment for the purchase) of noncontrolling interests
    		                                                                     
      net change in cash, cash equivalents and restricted cash
    		     -170,100,000 -148,300,000 124,700,000 -211,300,000 -23,200,000 -47,300,000 19,400,000 -97,000,000 -93,300,000 -252,100,000 495,200,000 -35,200,000 -88,700,000 14,900,000  -179,800,000 -48,500,000 117,000,000  13,500,000                                             
      cash, cash equivalents and restricted cash at beginning of year
    		                                                                     
      cash, cash equivalents and restricted cash at end of year
    		                                                                     
      supplemental cash flow information:
    		                                                                     
      net income
    		    40,300,000 7,600,000 52,000,000                                                               
      gain on sale of minority investment
    		                                                                     
      other non-cash incomes
    		    2,500,000                                                                 
      repayment of other debt
    		    -6,000,000    -2,500,000 -2,400,000 -2,100,000  -300,000 -500,000 -400,000 -100,000 -500,000 -1,300,000 -400,000                                                   
      proceeds from 2024 note purchase agreements
    		    0                                                                 
      proceeds from 2024 term loan agreements
    		    166,100,000                                                                 
      proceeds from other long-term debt
    		    700,000                                                                 
      repayment of 2012 note purchase agreement
    		    0 0 -100,000,000     0 0 0 -105,000,000                                                       
      repayment of 2019 term note agreement
    		    -3,800,000 -3,700,000 -3,800,000                                                               
      proceeds from (payment for) the sale (purchase) of noncontrolling interests
    		    0 -100,000 -900,000 -500,000 -1,500,000                                                             
      net (decrease) in cash, cash equivalents and restricted cash
    		                                                                     
      bargain purchase gain on acquisition
    		                                                                     
      purchases of short-term investments
    		                0    -50,000,000 0 -50,000,000  0                                             
      proceeds from issuance (repayment) of long-term debt
    		                                                                     
      repayment of 2019 term loan agreement
    		                                                                     
      impairment of strategic investments and other long-lived assets
    		        1,200,000                                                             
      gain on sale of strategic investment
    		        0                                                             
      proceeds from sale of strategic investment
    		        0                                                             
      cash paid for strategic investments
    		        -10,000,000 -1,100,000 -8,200,000 -19,400,000 -2,700,000                                                         
      repayment of 2019 note purchase agreement
    		        -3,800,000 -3,700,000 -3,800,000 -3,700,000 -800,000 -700,000 -800,000                                                       
      proceeds from the sale of noncontrolling interests
    		          5,300,000                                                           
      deferred revenue
    		           10,400,000 -2,400,000 -6,300,000 22,700,000 900,000 -600,000 5,900,000 14,100,000  500,000 -1,000,000 20,600,000  500,000 -4,700,000 13,900,000 -4,900,000 3,800,000 5,900,000  2,400,000 900,000 -2,400,000 -3,800,000 9,200,000    300,000 -3,100,000 5,000,000 -3,700,000 2,100,000 2,900,000                         
      customer advances
    		           31,800,000 -8,300,000 -17,800,000 22,600,000 28,000,000 -11,300,000 -700,000 2,500,000  10,600,000 5,300,000 16,500,000  -8,200,000 -7,400,000 6,500,000   17,800,000         8,900,000      3,700,000      13,800,000      5,900,000             
      proceeds from issuance of long-term debt
    		                                                                     
      proceeds (repayment) of other debt
    		                                 -100,000 -200,000 400,000                                  
      purchase of minority interest
    		           -1,200,000 -3,200,000                                                         
      payment of dividends to common stockholders
    		             -7,500,000 -7,500,000 -6,000,000 -6,100,000 -6,000,000 -6,100,000                                                   
      cash paid for strategic investments, at cost
    		              -12,000,000                                                       
      cash paid for acquisitions; net of cash acquired
    		              -83,800,000                                                       
      net proceeds from cross currency swap agreements
    		              300,000  7,100,000    3,600,000                                                 
      purchase of short-term investments
    		                                                                     
      purchase of investments held to maturity
    		                                                                     
      cash payments to noncontrolling interests
    		                                                                     
      purchases of investments held to maturity
    		                                                                     
      proceeds from other debt
    		                300,000 -200,000 300,000                                                   
      purchases of common stock
    		                0 -38,500,000 -32,600,000                                                   
      cash payments to noncontrolling interest
    		                                                                     
      impairment and other non-cash expenses
    		                                                                     
      purchase of available for sale debt securities
    		                                                                     
      proceeds from 2019 note purchase agreement
    		                                                                     
      proceeds from 2019 term loan agreement
    		                                                                     
      ​
    		                                                                     
      maturities of short-term investments
    		                           0 0 117,000,000 64,600,000 10,700,000 58,700,000 72,300,000 28,400,000 21,700,000 1,000,000                                 
      repayments of 2012 note purchase agreement
    		                                                                     
      proceeds of other debt
    		                          200,000                                           
      payment of dividends
    		                                                                     
      supplemental disclosure of cash flow information
    		                                                                     
      net proceeds from cross- currency swap agreements
    		                      1,900,000                                               
      repayments of note purchase agreement
    		                                                                     
      write-down of inventories to net realizable value
    		                                              7,300,000 6,800,000                      
      repayments of the note purchase agreement
    		                                                                     
      (repayment) proceeds of other debt
    		                                                                     
      excess tax benefit related to stock option awards
    		                                                                     
      write-down of demonstration inventories to net realizable value
    		                                2,800,000 4,000,000 3,700,000 4,800,000 5,100,000 4,900,000 5,000,000 7,400,000 7,600,000 7,600,000 8,000,000 8,200,000 7,800,000                         
      loss on disposal of product line
    		                                                                     
      changes in restricted cash
    		                                 -100,000   0 600,000 800,000                               
      excess tax benefits related to stock option awards
    		                                 0   0 0 2,200,000                               
      effect of exchange rate changes on cash and cash equivalents
    		                                 1,900,000 -1,200,000 5,800,000      2,200,000        5,000,000 6,500,000   200,000    -10,520,000            
      net change in cash and cash equivalents
    		                                    10,200,000 -13,700,000 15,000,000   15,300,000                     3,545,000   29,896,000 13,541,000 -17,625,388 3,299,000 
      cash and cash equivalents at beginning of period
    		                                 0 0 267,100,000 0 0 319,500,000 0 0 438,700,000 0 0 310,600,000 0 0 246,000,000 0 0 230,400,000 0 0 207,100,000 0 0 166,200,000 0 0 332,368,000 0 0 52,147,000  9,473,000 0 53,159,000   
      cash and cash equivalents at end of period
    		                                 46,200,000 22,600,000 209,900,000 10,200,000 -13,700,000 334,500,000 -60,600,000 -64,200,000 454,000,000 55,900,000 -18,500,000 269,400,000 1,800,000 10,800,000 229,500,000 26,000,000 -23,500,000 193,300,000 400,000 -15,500,000 203,100,000 -4,100,000 4,200,000 148,400,000 -41,018,000 -172,864,000 298,263,000 -3,029,000 -13,759,000 55,692,000  -52,445,000 29,896,000 66,700,000   
      gain on disposal of product line
    		                                    0                                 
      proceeds from disposal of product line
    		                                       12,100,000                              
      sales of property, plant and equipment
    		                                         600,000 200,000 0 600,000 800,000                        
      disposal of product line
    		                                         700,000 0 0 500,000                         
      proceeds from note purchase agreement
    		                                             0 0 240,000,000                      
      amortization of deferred financing costs
    		                                             200,000 100,000 200,000 100,000 200,000 100,000 200,000 100,000 200,000                
      stock-based compensation
    		                                             2,100,000 1,900,000 1,900,000 2,000,000 2,000,000 1,800,000 1,700,000 1,700,000 1,600,000 1,500,000 1,500,000 1,800,000             
      gain on disposal of business
    		                                                                     
      other non-cash expense
    		                                             800,000 -1,000,000 1,800,000 400,000   -1,200,000                  
      changes in operating assets and liabilities:
    		                                                                     
      acquisitions, net of cash acquired
    		                                                                     
      disposal of business
    		                                                                     
      (repayments) proceeds of revolving lines of credit
    		                                                                     
      non-cash financing activities:
    		                                                                     
      issuance of common stock in connection with acquisition of michrom bioresources inc.
    		                                                0                     
      customer deposits
    		                                               25,700,000 4,600,000     6,100,000                
      net cash from (used) in operating activities
    		                                               4,800,000                      
      repayment of term debt and capital leases
    		                                                                     
      net cash from (used) in financing activities
    		                                               14,800,000                      
      write down of inventories to net realizable value
    		                                                11,000,000                     
      loss on divestiture of business
    		                                                                     
      net cash (used) in provided by operating activities
    		                                                                     
      proceeds (repayments) of revolving lines of credit
    		                                                                     
      repayment of term debt
    		                                                                     
      write down of demonstration inventories to net realizable value
    		                                                  6,500,000                   
      gain on bargain purchase
    		                                                                     
      issuance of common stock under stock plans
    		                                                   500,000 600,000 1,600,000                
      other non-cash income
    		                                                                     
      net income attributable to bruker corporation
    		                                                                     
      gain on acquisition
    		                                                                     
      redemption of short-term investments
    		                                                           742,000      29,301,000 17,159,000   
      payments in connection with the acquisition of bruker biospin
    		                                                                     
      proceeds from (repayments of) short-term borrowings
    		                                                         -11,302,000 9,542,000 5,554,000          
      proceeds from (repayments of) long-term debt
    		                                                         -9,358,000 -175,008,000 353,297,000          
      proceeds from issuance of common stock, net of repurchases
    		                                                      500,000               
      deemed dividend in connection with the acquisition of bruker biospin
    		                                                                     
      cash payments to shareholders
    		                                                                     
      effective of exchange rate changes on cash and cash equivalents
    		                                                                     
      operating activities:
    		                                                                     
      adjustments to reconcile net income to cash flow from operating activities:
    		                                                                     
      other noncash reconciling items
    		                                                                     
      investing activities:
    		                                                                     
      payments in connection with the acquistion of bruker biospin
    		                                                                     
      proceeds from sale of short-term investments
    		                                                         -189,000            
      financing activities:
    		                                                                     
      payments of deferred financing costs
    		                                                                     
      deemed dividend in connection with the acquistion of bruker biospin
    		                                                                     
      purchases of property and equipment
    		                                                                     
      effect of exchange rate changes on cash
    		                                                           28,215,000 1,774,000 299,000 441,000 746,000 1,195,000 1,335,000 632,000   
      (repayments of) proceeds from short-term borrowings
    		                                                                     
      (repayments of) proceeds from long-term debt
    		                                                                     
      non-cash financing activities
    		                                                                     
      issuance of common stock related to acquisitions
    		                                                            0         
      repayments of long-term debt
    		                                                                     
      write down of investments and other non-cash charges
    		                                                                     
      benefit from doubtful accounts
    		                                                                     
      stock compensation
    		                                                                     
      minority interest in consolidated subsidiary
    		                                                                     
      gain on disposal of assets
    		                                                                     
      (gain) loss on fair market value of derivative instruments
    		                                                                     
      other assets and prepaid expenses
    		                                                                     
      accrued pension
    		                                                                     
      other liabilities
    		                                                                     
      restricted cash
    		                                                                     
      proceeds from (repayment of) short-term borrowings
    		                                                                     
      proceeds from issuance of common stock, net of issuance costs
    		                                                                     
      cash and cash equivalents at beginning of year
    		                                                                     
      cash and cash equivalents at end of year
    		                                                                     
      noncash investing and financing activities:
    		                                                                     
      issuance of common stock for bruker optics acquisition
    		                                                                     
      issuance of common stock for other acquisitions
    		                                                                     
      sales of short-term investments
    		                                                                     
      proceeds from (payments of) short-term borrowings
    		                                                                     
      proceeds from (payments of) long-term debt
    		                                                                     
      payments to shareholders
    		                                                                     
      proceeds from short-term borrowings
    		                                                                 100,000 1,459,000   
      other special charges
    		                                                                     
      loss on disposal of assets
    		                                                                     
      reversal of patent litigation settlement
    		                                                                     
      foreign currency exchange gain on intercompany loans
    		                                                                     
      issuance of long-term debt
    		                                                                     
      issuance of common stock for acquisition
    		                                                                     
      issuance of common stock and options exchanged related to merger
    		                                                                     
      purchases (redemptions) of short-term investments
    		                                                                     
      cash, cash equivalents and short-term investments at beginning of period
    		                                                                    0 
      cash, cash equivalents and short-term investments at end of period
    		                                                                    3,299,000 
      proceeds (repayment) of short-term borrowings
    		                                                                     
      proceeds (repayment) of long-term debt
    		                                                                     
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.